BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24517519)

  • 1. Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2⁻/⁻ mice.
    Bridle KR; Sobbe AL; de Guzman CE; Santrampurwala N; Jaskowski LA; Clouston AD; Campbell CM; Nathan Subramaniam V; Crawford DH
    Liver Int; 2015 Apr; 35(4):1451-63. PubMed ID: 24517519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
    Patsenker E; Schneider V; Ledermann M; Saegesser H; Dorn C; Hellerbrand C; Stickel F
    J Hepatol; 2011 Aug; 55(2):388-98. PubMed ID: 21168455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
    Toblli JE; Muñoz MC; Cao G; Mella J; Pereyra L; Mastai R
    Obesity (Silver Spring); 2008 Apr; 16(4):770-6. PubMed ID: 18239590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
    Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
    BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
    Tuncer I; Ozbek H; Ugras S; Bayram I
    Exp Toxicol Pathol; 2003 Sep; 55(2-3):159-66. PubMed ID: 14620537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
    Kim MY; Baik SK; Park DH; Jang YO; Suk KT; Yea CJ; Lee IY; Kim JW; Kim HS; Kwon SO; Cho MY; Ko SB; Chang SJ; Um SH; Han KH
    J Gastroenterol; 2008; 43(11):889-96. PubMed ID: 19012043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.
    Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Tsujinoue H; Fukui H
    Liver Int; 2005 Feb; 25(1):153-61. PubMed ID: 15698413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
    Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
    Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia.
    Ortlepp JR; Breuer J; Eitner F; Kluge K; Kluge R; Floege J; Hollweg G; Hanrath P; Joost HG
    Eur J Pharmacol; 2002 Feb; 436(1-2):145-50. PubMed ID: 11834258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
    El-Demerdash E; Salam OM; El-Batran SA; Abdallah HM; Shaffie NM
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):159-67. PubMed ID: 17900296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.
    Neo JH; Malcontenti-Wilson C; Muralidharan V; Christophi C
    J Gastroenterol Hepatol; 2007 Apr; 22(4):577-84. PubMed ID: 17376054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
    Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy.
    Saeedi Saravi SS; Ghazi-Khansari M; Ejtemaei Mehr S; Nobakht M; Mousavi SE; Dehpour AR
    World J Gastroenterol; 2016 May; 22(19):4685-94. PubMed ID: 27217700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY; Huang YL; Sun YH
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1053-6. PubMed ID: 16029550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophagic effect of the angiotensin AT1 receptor antagonist irbesartan in rats.
    Voigt JP; Bramlage P; Fink H
    Eur J Pharmacol; 2007 Jun; 564(1-3):131-7. PubMed ID: 17408613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the renin-angiotensin system improves the early stages of liver regeneration and liver function.
    Koh SL; Ager E; Malcontenti-Wilson C; Muralidharan V; Christophi C
    J Surg Res; 2013 Jan; 179(1):66-71. PubMed ID: 23110972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice.
    Le Corvoisier P; Adamy C; Sambin L; Crozatier B; Berdeaux A; Michel JB; Hittinger L; Su J
    Eur J Heart Fail; 2010 Nov; 12(11):1171-8. PubMed ID: 20870672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.